ATE182073T1 - Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung - Google Patents

Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung

Info

Publication number
ATE182073T1
ATE182073T1 AT94203112T AT94203112T ATE182073T1 AT E182073 T1 ATE182073 T1 AT E182073T1 AT 94203112 T AT94203112 T AT 94203112T AT 94203112 T AT94203112 T AT 94203112T AT E182073 T1 ATE182073 T1 AT E182073T1
Authority
AT
Austria
Prior art keywords
acid
granular product
grains
pharmaceutically active
water
Prior art date
Application number
AT94203112T
Other languages
English (en)
Inventor
Gerhard Gergely
Thomas Gergely
Irmgard Gergely
Stefan Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Application granted granted Critical
Publication of ATE182073T1 publication Critical patent/ATE182073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94203112T 1994-03-01 1994-10-26 Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung ATE182073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4406641 1994-03-01
CH87394 1994-03-23

Publications (1)

Publication Number Publication Date
ATE182073T1 true ATE182073T1 (de) 1999-07-15

Family

ID=25685969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94203112T ATE182073T1 (de) 1994-03-01 1994-10-26 Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung

Country Status (6)

Country Link
EP (1) EP0670160B1 (de)
KR (1) KR100358211B1 (de)
AT (1) ATE182073T1 (de)
DE (1) DE69419492T2 (de)
DK (1) DK0670160T3 (de)
ES (1) ES2136157T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
EP0803251B1 (de) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
US20030087005A1 (en) 1996-10-10 2003-05-08 Peter Baron Drink flavouring straw
AUPS270602A0 (en) 2002-05-31 2002-06-20 Baron, Peter Drink flavouring straw
US5807580A (en) * 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
FR2758265B1 (fr) * 1997-01-16 2004-08-13 Pf Medicament Microspheres effervescentes et leur procede de fabrication
AU2002300487B2 (en) * 1997-04-30 2006-04-27 Becton, Dickinson And Company Additive preparation and method of use thereof
US6225123B1 (en) 1997-04-30 2001-05-01 Becton Dickinson And Company Additive preparation and method of use thereof
US6534016B1 (en) * 1997-04-30 2003-03-18 Richmond Cohen Additive preparation and method of use thereof
WO1998056364A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
ATE241957T1 (de) * 1997-09-16 2003-06-15 Gergely Dr & Co Brausezubereitung und verfahren zu ihrer herstellung
ATE246915T1 (de) * 1998-11-23 2003-08-15 E Pharma Trento Spa Verfahren zur herstellung eines brausegranulats
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
AU2003251152A1 (en) * 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
US7588696B2 (en) 2003-06-12 2009-09-15 Cargill, Incorporated Antimicrobial water softener salt and solutions
US7090882B2 (en) 2003-06-12 2006-08-15 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US7658959B2 (en) 2003-06-12 2010-02-09 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US7883732B2 (en) 2003-06-12 2011-02-08 Cargill, Incorporated Antimicrobial salt solutions for cheese processing applications
US8486472B2 (en) 2006-01-18 2013-07-16 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
AR060029A1 (es) 2006-03-02 2008-05-21 Unistraw Patent Holdings Ltd Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
WO2013074046A1 (en) * 2011-08-08 2013-05-23 Mahmut Bilgic Pharmaceutical formulations comprising isoflavone
BR112014013639B1 (pt) * 2011-12-09 2022-05-10 Merck Patent Gmbh Carbonato de sódio cristalino, seus usos e seu processo de preparação
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
CN113975259B (zh) * 2021-09-14 2023-05-09 南京海纳医药科技股份有限公司 一种盐酸氨溴索复方泡腾片及其制备方法
CN114159399A (zh) * 2021-11-11 2022-03-11 大连双迪科技股份有限公司 一种口腔微泡含片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1039170A (en) * 1969-02-24 1971-07-22 Abbott Laboratories Tableting medium
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
CA2023493C (en) * 1989-08-31 2000-01-04 Masami Moroi Composition for foaming preparation
JP3517233B2 (ja) * 1991-07-01 2004-04-12 ゲルゲリイ、ゲルハルト 反応注入した発泡システム

Also Published As

Publication number Publication date
DE69419492T2 (de) 2000-02-03
EP0670160A1 (de) 1995-09-06
KR100358211B1 (ko) 2003-02-06
DK0670160T3 (da) 2000-02-14
ES2136157T3 (es) 1999-11-16
EP0670160B1 (de) 1999-07-14
KR970701038A (ko) 1997-03-17
DE69419492D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
ATE182073T1 (de) Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung
CA2183952A1 (en) Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
DE3873410D1 (de) Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung.
RU94046268A (ru) Микрогранулы омепразола и способ их получения
AU4113093A (en) Bioadhesive microspheres and their use as drug delivery and imaging systems
BG60261B2 (en) Lon-acting formulation of cefaclor
CA2059865A1 (en) Pharmaceutical Compositions Containing Orally Absorbable Glycosaminoglycans
NO953278L (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
WO2001003917A3 (de) Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren
CA2004598A1 (en) Medicinal aerosol formulations
CA2386690A1 (en) Pharmaceutical tramadol salts
AU5267900A (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
CA2009593A1 (en) Medicament containing dihydrolipoic acid as active substance
FI872577A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, hydrofobisen tai niukkaliukoisen aineen mikronisoitujen, hydrofilisoitujen hiukkasten valmistamiseksi
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
WO2001051026A3 (en) Instant granules and process for their formulation
CA2192086A1 (en) Pellets
IL146312A (en) 3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same
CA2265788A1 (en) Thermoplastic polyurethanes containing active substances
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
IT8323059A0 (it) Tripeptide e tetrapeptide alchilamidi biologicamente attive, processi per la loro preparazione e composizioni farmaceutiche che le contengono.
IT8323058A0 (it) Derivati di 2,5-piperazindione biologicamente attivi, processi per la loro preparazione e composizioni farmaceutiche che licontengono.
ES2057021T3 (es) Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.